Zhejiang Cheng Yi Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 476.22 million compared to CNY 523.73 million a year ago. Revenue was CNY 476.22 million compared to CNY 523.73 million a year ago.

Net income was CNY 102.53 million compared to CNY 118.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.3143 compared to CNY 0.3643 a year ago. Diluted earnings per share from continuing operations was CNY 0.3143 compared to CNY 0.3643 a year ago.